LOMUSTINE, VINDESINE AND BLEOMYCIN (LVB) USED IN THE TREATMENT OF RELAPSED ADVANCED HODGKINS-DISEASE - A PROSPECTIVE-STUDY ON BEHALF OF THE EAST OF SCOTLAND AND NEWCASTLE LYMPHOMA GROUP (ESNLG)

被引：14

作者：

LENNARD, AL ^{[1
]}

PROCTOR, SJ ^{[1
]}

DAWSON, AA ^{[1
]}

ALLAN, NC ^{[1
]}

PRESCOTT, RJ ^{[1
]}

PARKER, AC ^{[1
]}

LEONARD, RCF ^{[1
]}

ANGUS, B ^{[1
]}

DOBSON, C ^{[1
]}

RITCHIE, GL ^{[1
]}

LUCRAFT, HH ^{[1
]}

SCOTT, S ^{[1
]}

机构：

[1] ROYAL VICTORIA INFIRM,DEPT HAEMATOL,QUEEN VICTORIA RD,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND

来源：

HEMATOLOGICAL ONCOLOGY | 1989年 / 7卷 / 01期

关键词：

D O I：

10.1002/hon.2900070109

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：77 / 86

页数：10

共 21 条

[1] THE PROGNOSTIC-SIGNIFICANCE OF CELLULAR SUBTYPES IN NODULAR SCLEROSING HODGKINS-DISEASE - AN ANALYSIS OF 271 NON-LAPAROTOMIZED CASES (BNLI REPORT NO 22) [J].

BENNETT, MH ;

MACLENNAN, KA ;

EASTERLING, MJ ;

HUDSON, BV ;

JELLIFFE, AM ;

HUDSON, GV .

CLINICAL RADIOLOGY, 1983, 34 (05) :497-501

[2]

BONADONNA G, 1985, SEMIN ONCOL, V12, P1

[3]

BONADONNA G, 1985, SEMIN ONCOL, V12, P23

[4]

COOPER MR, 1980, CANCER, V46, P654, DOI 10.1002/1097-0142(19800815)46:4<654::AID-CNCR2820460405>3.0.CO

[5]

2-A

[6] CURABILITY OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY [J].

DEVITA, VT ;

SIMON, RM ;

HUBBARD, SM ;

YOUNG, RC ;

BERARD, CW ;

MOXLEY, JH ;

FREI, E ;

CARBONE, PP ;

CANELLOS, GP .

ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :587-595

[7] PROLONGED DISEASE-FREE SURVIVAL IN HODGKINS-DISEASE WITH MOPP REINDUCTION AFTER 1ST RELAPSE [J].

FISHER, RI ;

DEVITA, VT ;

HUBBARD, SP ;

SIMON, R ;

YOUNG, RC .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (05) :761-763

[8]

GOLDMAN JM, 1975, LANCET, V2, P1224

[9]

GOLDMAN JM, 1981, LANCET, V1, P252

[10] MIME CHEMOTHERAPY (METHYL-GAG, IFOSFAMIDE, METHOTREXATE, ETOPOSIDE) AS TREATMENT FOR RECURRENT HODGKINS-DISEASE [J].

HAGEMEISTER, FB ;

TANNIR, N ;

MCLAUGHLIN, P ;

SALVADOR, P ;

RIGGS, S ;

VELASQUEZ, WS ;

CABANILLAS, F .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :556-561

← 1 2 3 →